Mon.Dec 05, 2022

article thumbnail

TherapeuticsMD to offload drugs to Australia’s Mayne after failed buyout

Bio Pharma Dive

After a private equity takeover unraveled this summer, the women’s health company is selling its drug portfolio to Mayne Pharma in a $153 million deal.

Drugs 329
article thumbnail

Sanofi and Queensland collaborate to build $190m research facility

Pharmaceutical Technology

Sanofi has signed an agreement with the Queensland Government in Australia to establish a $190m (A$280m) research facility in Brisbane. With the establishment of this Translational Science Hub, Queensland is set to become an international messenger ribonucleic acid (mRNA) vaccine hub. According to the latest deal, the University of Queensland (UQ) and Griffith University will serve as foundational partners.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Novartis prostate cancer drug succeeds in study key to company’s sales hopes

Bio Pharma Dive

The positive results could help Novartis secure approval for earlier use of the radiopharmaceutical drug Pluvicto, potentially broadening the number of eligible patients by several times the current market.

Drugs 301
article thumbnail

Cannabinoids receptors: popular preclinical target but banned in 137 countries

Pharmaceutical Technology

Cannabinoid receptors are a popular therapeutic target for cannabinoid-based drugs in the treatment of pain, neurological disorders and inflammation, according to GlobalData’s Pharma Intelligence Centre Drugs database. In 2022, a surge in the pipeline has led to cannabinoid receptors becoming the most popular target in preclinical development. Despite this, the medical use of cannabinoid drugs is heavily restricted, including being banned in 137 countries, according to the United Nations.

Drugs 245
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

When it comes to small populations, biotechs need to think big

Bio Pharma Dive

Maria-Cruz Morillo, global therapeutic operations lead for rare diseases at Allucent, discusses the unique challenges of rare disease drug development and how the right expertise can help.

Drugs 274
article thumbnail

Lupkynis approved for the treatment of LN in the EU and UK

Pharmaceutical Technology

On September 19, Lupkynis (voclosporin), a therapy for lupus nephritis (LN), received European Commission (EC) approval, becoming the second therapy approved in the EU for the treatment of LN after Benlysta (belimumab) from GlaxoSmithKline. The UK Medicines and Healthcare products Regulatory Agency (MHRA) has also since granted the Great Britain marketing authorisation of Lupkynis to treat adults with active LN.

More Trending

article thumbnail

AstraZeneca’s IT hiring activity declines 3.1% in November 2022

Pharmaceutical Technology

UK-based company AstraZeneca’s IT hiring declined 3.1% in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity increased by 2.15% in November 2022 when compared with October 2022. IT jobs claimed an 8.36% share in the company’s total hiring activity in November 2022, and recorded a 0.26% decline over the last three-month average share.

article thumbnail

How a government biologist with the USDA built her community — and her career — at Regis University

Bio Pharma Dive

When Talisa Puentes-Ortega got the chance to advance her career by going back to school, Regis provided more than an environmental biology degree — it was the foundation of a community that continues to support her.

246
246
article thumbnail

Eurofins Scientific’s IT hiring activity declines 10.6% in November 2022

Pharmaceutical Technology

Luxembourg-based company Eurofins Scientific’s IT hiring declined 10.6% in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity declined by 10.33% in November 2022 when compared with October 2022. IT jobs claimed a 5.73% share in the company’s total hiring activity in November 2022, and recorded a 0.26% growth over the last three-month average share.

article thumbnail

With new data, Nkarta builds case for ‘natural killer’ cell therapy

Bio Pharma Dive

The updated study results add to evidence that such therapies may help treat B-cell lymphomas. But it’s still unclear how long their effects could last.

196
196
article thumbnail

Running Decentralized Trials at Scale: Planning for Success

There’s been a rapid shift towards decentralization in clinical trials & it’s clear why. The potential for reaching a larger pool of recruits is possible when sponsors can bring more trial activities to the patient. Tele visits, digital consent, new monitoring sensors, & direct-to-patient supply are virtual tools that existed before the pandemic, but now there’s swift adoption of these methods because they’ve been proven to help launch & complete trials more effectively.

article thumbnail

MerckInc’s IT hiring activity declines 8.6% in November 2022

Pharmaceutical Technology

US-based company MerckInc’s IT hiring declined 8.6% in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity declined by 13.09% in November 2022 when compared with October 2022. IT jobs claimed a 4.99% share in the company’s total hiring activity in November 2022, and recorded a 0.4% decline over the last three-month average share.

article thumbnail

J&J drops out of hunt for Horizon, leaving Sanofi and Amgen to bid

Bio Pharma Dive

The two remaining suitors said they would make cash bids if they move forward with offers, for which they must declare “firm intent” by Jan. 10 under Irish takeover rules.

144
144
article thumbnail

Parexel International’s IT hiring activity declines 3.0% in November 2022

Pharmaceutical Technology

US-based company Parexel International’s IT hiring declined 3.0% in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity declined by 9.68% in November 2022 when compared with October 2022. IT jobs claimed a 13.42% share in the company’s total hiring activity in November 2022, and recorded a 1.54% growth over the last three-month average share.

Scientist 130
article thumbnail

Childhood health equity: The urgent need to do things differently—now

Medical Xpress

Despite years of research, discussions and advocacy in relation to nurturing children's development through healthy eating and active living, there's been very little in the way of progress—sugary drinks are still advertised prolifically, there's hidden salt and sugar in foods, and most kids spend more time in front of screens rather than outside.

Research 125
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Syneos Health’s IT hiring activity declines 4.2% in November 2022

Pharmaceutical Technology

US-based company Syneos Health’s IT hiring declined 4.2% in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The company’s overall hiring activity declined by 11.94% in November 2022 when compared with October 2022. IT jobs claimed a 10.55% share in the company’s total hiring activity in November 2022, and recorded a 1.46% growth over the last three-month average share.

article thumbnail

Pedestrians choose healthy obstacles over boring pavements, study finds

Medical Xpress

Up to 78% of walkers would take a more challenging route featuring obstacles such as balancing beams, steppingstones and high steps, research has found. The findings suggest that providing 'Active Landscape' routes in urban areas could help tackle an "inactivity pandemic" and improve health outcomes.

Research 123
article thumbnail

Incyte signs partnership agreement with CMS for ruxolitinib cream

Pharmaceutical Technology

Incyte has signed a partnership and licence agreement with CMS subsidiary CMS Aesthetics to develop and market ruxolitinib cream to treat autoimmune and inflammatory dermatologic ailments in Greater China and some Southeast Asian countries. According to the deal, Incyte is entitled to receive an upfront payment from CMS, which will also make further potential payments on meeting development, regulatory and commercial milestones.

article thumbnail

WHO/PAHO launch free digital health assistant to cut alcohol-related diseases

pharmaphorum

A digital health assistant that can help people at risk of becoming dependent on alcohol has been launched in Belize, its first country, by the World Health Organisation (WHO) and Pan-American Health Organisation (PAHO). The artificial intelligence-powered assistant – called Pahola and available as a free online chat-based site – is designed to provide information and guidance to help people reduce their alcohol consumption, helping to prevent more than 200 health conditions linked to excessive

Drugs 122
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

TherapeuticsMD and Mayne sign product licensing agreements

Pharmaceutical Technology

Women’s healthcare company TherapeuticsMD has sign ed agreements for licensing its products to the Mayne Pharma affiliate in the US. According to the definitive agreements, Mayne will obtain an exclusive licence for commercialising TherapeuticsMD’s Imvexxy and Bijuva, as well as its prescription prenatal vitamin products marketed under the brands namely BocaGreenMD and vitaMedMD.

Licensing 130
article thumbnail

How one artist took on the Sacklers and shook their reputation in the art world

NPR Health - Shots

A new documentary All The Beauty and the Bloodshed tells the story of Nan Goldin, a photographer and activist who survived opioid addiction — then challenged members of the Sackler family.

115
115
article thumbnail

Spain’s pharma industry IT recruitment activity drops 9.1% in November 2022

Pharmaceutical Technology

Spain’s pharma industry registered a 9.1% drop in IT hiring activity in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring is decreased by 15.22% in November 2022 when compared with October 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 10.51% share in November 2022, recording an increase of 1.01% over the last three-month average share.

article thumbnail

STAT+: The health insurer will see you now: How UnitedHealth is keeping more profits, as your doctor

STAT News

Next year, UnitedHealth Group — one of the largest health care companies on the planet — expects to make a lot more money in a relatively simple way: by funneling more of the insurance premiums it collects from workers and taxpayers toward itself. That’s possible because UnitedHealth, known for its sprawling insurance presence, has pivoted to become one of the largest providers of outpatient care by acquiring numerous physician practices, surgery centers, urgent care facilit

Doctors 105
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

UK pharma industry IT recruitment activity drops 25.9% in November 2022

Pharmaceutical Technology

The UK’s pharma industry registered a 25.9% drop in IT hiring activity in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring is decreased by 36.99% in November 2022 when compared with October 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 1.37% share in November 2022, recording a decrease of 1.1% over the last three-month average share.

article thumbnail

For patients with sickle cell disease, fertility care is about reproductive justice

NPR Health - Shots

The disease, which predominantly affects patients of color, can damage the body in ways that can make it difficult to have a child. But patients don't always have access to fertility care.

105
105
article thumbnail

Switzerland’s pharma industry IT recruitment activity drops 25.4% in November 2022

Pharmaceutical Technology

Switzerland’s pharma industry registered a 25.4% drop in IT hiring activity in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring is decreased by 19.13% in November 2022 when compared with October 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 2.94% share in November 2022, recording a decrease of 0.13% over the last three-month average share.

article thumbnail

Progress Flickers in Women’s Healthcare as Femtech Builds Traction

BioSpace

The worldwide market for therapeutics designed specifically for conditions and diseases that affect mainly women is expected to exceed $65 billion by 2027. BioSpace looks at three femtech leaders.

Marketing 101
article thumbnail

2022 Research: The Rapid Rise of Ocean Freight Visibility

A research study conducted by The Journal of Commerce and FourKites surveyed hundreds of international shippers, exploring how their usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19. For international shippers, ocean freight visibility has evolved from optional to essential and satisfaction with visibility varies greatly depending on how it is obtained and delivered.

article thumbnail

US pharma industry IT recruitment activity drops 15.6% in November 2022

Pharmaceutical Technology

The US’s pharma industry registered a 15.6% drop in IT hiring activity in November 2022 when compared with the previous month, according to GlobalData’s Job Analytics database. The industry’s overall hiring is decreased by 11.32% in November 2022 when compared with October 2022. Out of the pharma industry’s total hiring activity, IT jobs claimed a 1.57% share in November 2022, recording a decrease of 0.17% over the last three-month average share.

article thumbnail

Immunotherapy eliminates disease-causing cells in mice with MS-like disease

Medical Xpress

The cancer therapy known as CAR-T has revolutionized treatment of some blood cancers since it was introduced in 2017. The therapy uses genetically altered immune cells to home in on cancer cells and destroy them.

article thumbnail

Opinion: Congress needs to update FDA’s ability to regulate diagnostic tests, cosmetics

STAT News

Congress is considering two measures that modernize tools the Food and Drug Administration uses to oversee two areas of its vast portfolio: diagnostic tests and cosmetics. While the stakes are different for each of these industries, the basic premise driving these measures is the same. The FDA is currently working from an outdated regulatory playbook that has left gaps in its oversight of safety and effectiveness and makes it more difficult to introduce new innovations.

article thumbnail

Reading for pleasure strengthens memory in older adults

Medical Xpress

Baseball may be America's favorite pastime, but in rankings of the most popular hobbies, reading is more consistently ranked highly. It's not hard to see why: reading is simultaneously engaging and relaxing, and it's fun to do alone and with friends.

98
article thumbnail

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Are you currently in sales, or involved in a business that depends on strong sales results? What about the extremely competitive world of medical device sales? What are some of the top challenges your customers face and how do you approach understanding what’s most important to them? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC., to discover critical strategies and approaches you can take to engage your customers, achieve g